WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009063241) 3-HYDROXYANTHRANILIC ACID OR SALTS THEREOF1 FOR TREATING CANCER OR INFECTIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/063241    International Application No.:    PCT/GB2008/051059
Publication Date: 22.05.2009 International Filing Date: 13.11.2008
IPC:
A61K 31/196 (2006.01), A61K 38/19 (2006.01), A61K 39/015 (2006.01), A61K 39/04 (2006.01), A61K 39/12 (2006.01), A61K 45/06 (2006.01), A61P 31/06 (2006.01), A61P 31/08 (2006.01), A61P 31/12 (2006.01), A61P 31/18 (2006.01)
Applicants: LUDWIG INSTITUT FUR KREBSFORSCHUNG AG [US/US]; 605 Third Avenue, New York, NY 10158 (US) (For All Designated States Except US).
THE CHANCELLER, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD [GB/GB]; Wellington Square, Oxford Oxfordshire OX1 2JD (GB) (For All Designated States Except US).
SCHOFIELD, Christopher, Joseph [GB/GB]; (GB) (For US Only).
CERUNDOLO, Vincenzo [IT/GB]; (GB) (For US Only)
Inventors: SCHOFIELD, Christopher, Joseph; (GB).
CERUNDOLO, Vincenzo; (GB)
Agent: WRIGHT, Gordon; Elkington And Fife Llp, Prospect House, 8 Pembroke Road, Sevenoaks Kent TN13 1XR (GB)
Priority Data:
0722274.8 13.11.2007 GB
Title (EN) 3-HYDROXYANTHRANILIC ACID OR SALTS THEREOF1 FOR TREATING CANCER OR INFECTIONS
(FR) ACIDE 3-HYDROXYANTHRANILIQUE ET SES SELS DANS LE TRAITEMENT DU CANCER OU D'INFECTIONS
Abstract: front page image
(EN)24 Abstract This invention relates to a novel inhibitor of indoleamine 2,3-dioxygenase (IDO) and its use in the treatment of cancer or infections, either alone or in combination with additional therapeutic agents.
(FR)La présente invention concerne un nouvel inhibiteur de l'indole-amine 2,3-dioxygénase (IDO) et son utilisation dans le traitement du cancer ou d'infections, soit seul soit en combinaison avec d'autres agents thérapeutiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)